dc.contributor.author | Zhang, Wei | |
dc.contributor.author | Gungor, Zeynep | |
dc.contributor.author | Enkhmaa, Byambaa | |
dc.contributor.author | Kim, Kyoungmi | |
dc.contributor.author | Berglund, Lars | |
dc.contributor.author | Anuurad, Erdembileg | |
dc.date.accessioned | 2021-03-05T20:43:28Z | |
dc.date.available | 2021-03-05T20:43:28Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Gungor Z., Anuurad E., Enkhmaa B., Zhang W., Kim K., Berglund L., "Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk", ATHEROSCLEROSIS, cilt.223, ss.230-234, 2012 | |
dc.identifier.issn | 0021-9150 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_d5884d73-64a0-44d1-b2b4-75306e38cd13 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/140896 | |
dc.identifier.uri | https://doi.org/10.1016/j.atherosclerosis.2012.04.021 | |
dc.description.abstract | Objective: Apolipoprotein E (apoE) has been implicated as conveying increased risk for coronary artery disease (CAD). Previous studies suggest a role of apoE as a modulator of immune response and inflammatory properties. We hypothesized that the presence of apo E-4 is associated with an increased inflammatory burden in subjects with CAD as compared to subjects without CAD. | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Kardiyoloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | PERİFERAL VASKÜLER HASTALIĞI | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | CARDIAC ve CARDIOVASCULAR SİSTEMLER | |
dc.title | Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk | |
dc.type | Makale | |
dc.relation.journal | ATHEROSCLEROSIS | |
dc.contributor.department | University of California System , , | |
dc.identifier.volume | 223 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 230 | |
dc.identifier.endpage | 234 | |
dc.contributor.firstauthorID | 204931 | |